PatternsRadar
Sign in

GUJTHEMGujarat Themis Biosyn Limited

NSE
352.70INR-6.50 (-1.81%)Close · 20 Nov 2026
14 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹4,590 CrMarket cap
—P/E (TTM)
65.1%Delivery

Filings & corporate actions

9 results filed
CSV
Next results · Q3 FY27
Expected 1 Feb 2027 – 24 Feb 2027
Estimate: filed 32–55 days after quarter end, last 7 times
Dividend
₹0.67 per share · last 23 Sept 2026
2026
  • 14 NovresultsResults · Q2 FY27 · consolidated and standalone-7.6%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-4.0%NSE
  • 23 SeptdividendDividend · ₹0.67 per share · record 23 Sept 2026-0.2%
  • 10 SeptshareholdingShareholding · 28 Aug 2026-0.2%NSE
  • 7 AugresultsResults · Q1 FY27 · consolidated and standalone+3.3%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026-1.5%NSE
  • 20 JunresultsResults · Q4 FY26 · standalone+4.9%NSE
  • 25 MayresultsResults · Q4 FY26 · standalone-5.6%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+4.4%NSE
  • 5 FebresultsResults · Q3 FY26 · standalone-1.4%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-3.5%NSE

Reaction to results · all yearsrose on day 0 in 1 of 7 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2714 Nov 2026-7.6%——1.4×
Q1 FY277 Aug 2026+3.3%-1.3%+20.6%1.2×
Q4 FY2625 May 2026-5.6%+3.2%+3.0%1.3×
Q3 FY265 Feb 2026-1.4%-4.9%-13.7%0.3×
Q2 FY2610 Nov 2025-0.8%-4.1%-15.1%0.4×
Q1 FY261 Aug 2025-4.6%-13.1%-3.6%1.7×
Q4 FY2520 May 2025-3.8%-5.9%0.0%2.8×
Average-2.9%-4.4%-1.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+14.0%
Profit QoQ-225.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open353.80
Day range351.00 – 361.90
52-week range225.05 – 470.05
From 52w high-25.0%
RSI (14)42.3
ATR (14)17.71
Volume47.4K
Avg volume (20D)1.53L
Rel volume0.31×
Volatility (1Y)53.0%
Turnover₹1.7Cr
Traded value (NSE)₹1.7Cr
VWAP354.33
SMA 50 / 200383.04 / 359.34
Price band20%

Delivery percentage

Latest · 20 Nov 202665.1%
20-day avg51.5%
1-year avg52.4%
Percentile (own history)89th
Range6.9–89.7%
Sessions429

Over the last 20 sessions GUJTHEM settled 51.5% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 52.4%. The latest session ranks higher than 89% of the 429 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.19%
Dividend, trailing 12M₹0.67
Paid every year for2 yr
Shareholders28.8K · +7.0% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy58 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.81%-9.25%-0.20%-4.48%-1.23%-21.08%

Valuation

Market cap₹4,590 Cr
Market cap (NSE)₹4,590 Cr
Free-float cap₹1,867 Cr
P/E (TTM)—
P/E (NSE)227.2
EPS (TTM)—
P/B4.5
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity1.41
Shares outstanding13.02Cr
Listed25 Feb 2025

Ownership

Promoter59.33%
Promoter Δ QoQ0.00 pp
Public40.67%
FII3.80%
DII12.65%
Pledged0.00%

Quarterly results · consolidated

Q1 FY27Q2 FY27
Revenue (₹ Cr)43.849.9
YoY chg——
Net profit (₹ Cr)11.1(13.8)
YoY chg——
Net margin25.3%-27.7%
EPS1.020.00

Shareholding over time

By quarter

30 Sept 2026 · promoter 59.33% · public 40.67%
21 Feb 2025: promoter 70.86%31 Mar 2025: promoter 70.86%30 Jun 2025: promoter 70.86%30 Sept 2025: promoter 70.86%31 Dec 2025: promoter 70.86%31 Mar 2026: promoter 70.86%30 Jun 2026: promoter 70.86%28 Aug 2026: promoter 59.33%30 Sept 2026: promoter 59.33%
2025-022026-09
  • Promoter
  • Public and others
Promoter
59.33%
Public
40.67%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
3.80%
DII
12.65%
Promoter pledged
0.00%

Who the public is

Mutual funds
9.63%

-0.03 pp QoQ

Insurance
2.17%

0.00 pp QoQ

FPI
3.80%

-1.13 pp QoQ

Retail ≤ ₹2L
13.15%

+0.34 pp QoQ

HNI > ₹2L
3.38%

-0.24 pp QoQ

NRI
1.03%

0.00 pp QoQ

Bodies corporate
4.81%

+2.16 pp QoQ

Shareholders
28,781

+7.0% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
PHARMACEUTICAL BUSINESS GROUP [INDIA] LTDPromoter · Corporate38.97%
THEMIS MEDICARE LIMITEDPromoter · Corporate17.50%
QUANT MUTUAL FUND - QUANT MANUFACTURING FUNDMutual fund7.47%
AYUSHMAT LTDFPI2.55%
SACHIN DINESH PATELPromoter · Individual2.32%
KOTAK MAHINDRA LIFE INSURANCE COMPANY LTDInsurance2.17%
BANK OF INDIA FLEXI CAP FUNDMutual fund1.63%
Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (Trustees of Vividhmargi Trust)Promoter · Individual0.51%
ANAY RUPEN CHOKSIPromoter · Individual0.02%
NYSHA RUPEN CHOKSIPromoter · Individual0.02%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 4 Sept 2025 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.67₹0.67
FY2025-261₹0.67₹0.67
Ex-dateRecord dateDeclaredAdjusted
23 Sept 202623 Sept 2026₹0.67₹0.67
4 Sept 2025—₹0.67₹0.67

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Bulk & block deals · 23 Sept 2026

CSV
4 of 4 deals
By year
DateDealClientQuantityPriceValue
23 Sept 2026Sell · bulkL7 HITECH PRIVATE LIMITED6.53L410.72₹26.8Cr
23 Sept 2026Buy · bulkL7 HITECH PRIVATE LIMITED100413.37₹41,337
24 Apr 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED5.91L367.48₹21.7Cr
24 Apr 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED5.91L367.22₹21.7Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Zero EPS (4 quarters) · since 16 Nov 2026 — Zero EPS over the last four quarters.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q1 FY27Q2 FY27
Revenue from operations43.849.9
Other income0.13.8
Total income43.953.7
Total expenses28.863.7
└ Finance costs1.88.4
└ Depreciation4.04.5
Profit before tax15.2(11.2)
Tax expense4.12.7
Net profit11.1(13.8)
EPS1.02-1.19
Net margin25.27%-27.73%
PBT margin34.63%-22.38%
Tax rate27.03%—

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 14 Nov 2026.

2 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 H1 FY27
Total assets2,673.8
Current assets552.8
└ Cash & equivalents132.4
└ Other bank balances11.6
└ Current investments0.0
└ Trade receivables113.1
└ Inventories267.3
Total equity1,023.2
└ Attributable to owners1,023.2
└ Share capital13.0
Borrowings1,446.7
└ Current80.6
└ Non-current1,366.2
Trade payables67.2
Current liabilities252.6
Total liabilities1,650.6
Net debt1,302.7
Debt / equity1.41
Current ratio2.19

Cash flow, year to date

 H1 FY27
Operating cash flow(4.9)
└ Capex(54.0)
Free cash flow(58.9)
Investing cash flow(1,120.6)
Financing cash flow1,266.4
└ Dividends paid0.0
└ Buybacks0.0
Net change in cash140.9

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

GUJTHEM at a glance

  • GUJTHEM closed at ₹352.7 on 20 Nov 2026, -1.81% on the day, -21.1% over one year, 25.0% below its 52-week high of ₹470.05.
  • Delivery was 65.1% of traded quantity on 20 Nov 2026, the 89th percentile of its own 429 sessions with a reading (20-session average 51.5%, 1-year average 52.4%).
  • Market capitalisation is ₹4,590 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 14 Nov 2026): revenue ₹50 crore, net profit ₹-14 crore; the price moved -7.6% on the first session after.
  • Promoters held 59.33% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 1 Feb 2027 and 24 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE942C01045
SeriesEQ
Listed25 Feb 2025
NSE market cap · 17 Nov 2026₹4,542 Cr
Free-float market cap (NSE)₹1,841 Cr
Shares outstanding (NSE)13.02Cr
History from25 Feb 2025
Sessions429

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.